1 The effects of increases in intracellular adenosine 3' :5'-cyclic monophosphate (cyclic AMP) on mitogen-induced generation of inositol phosphates and increases in intracellular Ca2+ concentration were investigated in human peripheral blood mononuclear leukocytes (MNL). 2 The mitogens concanavalin A (Con A), pokeweed mitogen (PWM) and phytohaemagglutinin (PHA) concentration-dependently stimulated generation of inositol phosphates. Catecholamines inhibited this process with an order of potency: isoprenaline > adrenaline > noradrenaline indicating involvement of f2-adrenoceptors. This order of potency was also consistent with the catecholamine potencies for stimulating the generation of cyclic AMP.
Introduction
The function of the immune system is regulated by various neurotransmitters and hormones. Of special interest are those agents which elevate lymphocyte adenosine 3':5'-cyclic monophosphate (cyclic AMP) concentrations because they can inhibit lymphocyte function in multiple ways in vitro (for reviews see Bourne et al., 1974; Felten et al., 1987; Kammer, 1988) . For example, it has been demonstrated that cyclic AMP increasing hormones can inhibit mitogen-stimulated lymphocyte proliferation, antibody formation by B-cells, and cytolytic activity of T-cells. These inhibitory effects of cyclic AMP formation stimulating hormones are mediated by cyclic AMP because they can also be elicited by receptor-independent stimulation of cyclic AMP formation (e.g. by the diterpene forskolin) and by compounds mimicking cyclic AMP (e.g. . Moreover, some data suggest that cyclic AMP increasing agents can also impair immune function in vivo. For example it has been shown that prolonged exposure to fJ-adrenoceptor agonists can decrease the number of thymocytes in mice (Durant, 1986 ) and of circulating lymphocytes in man (Maisel et al., 1990) .
The activation of resting lymphocytes is a multistep process involving early biochemical alterations such as formation of inositol phosphates and increases in intracellular Ca2 + leading to activation of a protein kinase C, which occur during the first seconds and minutes of lymphocyte activation (Tsien et al., 1982; Wolff & Akerman, 1982; Taylor et al., 1984; Sugiura & Waku, 1984; Chen et al., 1986; Cambier et al., 1987; Hadden, 1988) . These early alterations are followed within a couple of hours by later events such as secretion of interleukin-2 (IL-2), and expression of IL-2 receptors and certain oncogenes. This second wave of biochemical events can also be inhibited by elevations of intracellular cyclic AMP (Feldman et al., 1987; Mary et al., 1987; Johnson et al., 1988; Kammer, 1988) . As secretion of IL-2 and expression of IL-2 receptors depend on an elevation of intracellular Ca2 + and an activation of a protein kinase C (Cambier et al., 1987; Hadden, 1988) , it is possible that cyclic AMP formation stimulating agents inhibit lymphocyte activation by attenuating the generation of these early biochemical signals. Cyclic AMP measurements Accumulation of cyclic AMP was measured in intact MNL according to previously published techniques (Brodde et al., 1985 (Motulsky & Michel, 1988 As other investigators have reported enhanced hormonestimulated cyclic AMP accumulation in the presence of mitogenic lectins (Fredholm et al., 1987; Dailey et al., 1988) , we also determined isoprenaline-stimulated cyclic AMP accumulation following exposure to mitogens for 30min. This protocol was chosen to yield a mitogen exposure of the MNL comparable to that during the inositol phosphate accumulation experiments. However, neither PWM (2.4pgml-1) nor PHA (1.8 pg ml -) significantly altered the potency or maximal effects of isoprenaline on MNL cyclic AMP accumulation (Figure 1 ).
Inositol phosphate accumulation
Incubation of MNL, prelabelled with [3H]-myo-inositol, with various concentrations of PHA (0.2-14.4,ugml-1), Con A (0.14-36pgm1-1) and PWM (0.15-4.8,ugml-1) for 30min at 370C concentration-dependently increased the formation of [3H]-inositol phosphates ( Figure 2) ; the maximal effect was highest for Con A and PHA and lowest for PWM. All further experiments were performed using 1.8 pg ml-1 PHA, 18puggml-' Con A, and 2.4 pggml-' PWM.
f6-Adrenoceptor agonists decreased mitogen-stimulated inositol phosphate generation by 30-50% depending on the mitogen used (Figure 3a-c) . The maximal inhibitory effect was similar for all three catecholamines but their potency differed, the rank order being: isoprenaline > adrenaline > noradrenaline ( Figure 3 Figure 4a -c).
In order to investigate whether the inhibitory effects of the catecholamines are related to their stimulation of cyclic AMP generation, we studied the effects of PGE1 and forskolin (which stimulate cyclic AMP generation independently of fiadrenoceptor activation) and of the phosphodiesterase inhibitor isobutylmethylxanthine (IBMX). Forskolin, a poor stimulator of cyclic AMP generation in resting human MNL (see Table 1 ) weakly reduced mitogen-stimulated inositol phosphate generation (20-35% inhibition; Figure 5a -c). In contrast, PGE1 (which stimulates cyclic AMP generation considerably more than the catecholamines, see Table 1 ) inhibited mitogen-stimulated inositol phosphate accumulation to a much larger extent than the catecholamines (Figure 5a-c) . Moreover, IBMX (0.1 mM) considerably enhanced the inhibition of mitogen-stimulated inositol phosphate generation by isoprenaline ( Figure 6 ). Thus, inhibition of inositol phosphate generation by these various cyclic AMP promoting agents was strongly related to the increase in the intracellular level of cyclic AMP. 
Increases ofintracellular Ca"2+ concentrations
The basal intracellular Ca2+ concentration was 62 + 5 nm (n = 12 with 8-22 replicates in each experiment). Con A and PHA concentration-dependently elevated intracellular Ca2+ to a peak level within 1-3 min; as expected, the Ca2+ concentration later declined from the peak to a plateau above the basal level which was maintained for more than 30 min (data not shown). From the peak Ca2+ concentration elicited by 4 mitogen concentrations we constructed concentrationresponse curves (Figure 7) . PWM elicited only very small and inconsistent increases of intracellular Ca2+ (maximally 25 nM at 96jugml-1) regardless of whether experiments were performed at 250C or 370C (data not shown). Chelation of extracellular Ca2+ by addition of 5mM EGTA immediately prior to the mitogens completely abolished the Ca2 + increases stimulated by Con A and PHA (n = 4; data not shown). Thus, the mitogen-induced increases in intracellular Ca2+ were predominantly due to influx rather than intracellular mobilization in accordance with recently reported data in human and murine resting lymphocytes (Alcover et al., 1987; Linch et al., 1987; Gelfand et al., 1987) . mitogen-stimulated Ca2+ increases (data not shown). Such a lack of effect of pertussis toxin on the inhibition of Ca2+ increases has previously also been reported in human and murine-T-lymphocytes (Macintyre et al., 1988; Aussel et al., 1988; Gray et al., 1989; Stewart et al., 1989) . The cyclic AMP generation-stimulating agents PGE1
(10pM), forskolin (20pM) and isoprenaline (10pM) did not significantly alter the intracellular Ca2 + concentration of resting MNL (2 + 2 nm for PGE1, 1 + 0 nm for forskolin, and 1 + 1 nm for isoprenaline, n = 4-8 each). However, all three agents inhibited the PHA-and Con A-stimulated Ca2+ elevations (Figure 8) . Inhibition of the Ca2 + elevation was associated with a prolonged time-to-peak (data not shown) which was not quantified in detail. Inhibition of PWMstimulated Ca2 + increases was not tested because these increases were too small and inconsistent to begin with (see above). Blocking the degradation of cyclic AMP with the phosphodiesterase inhibitors IBMX (0.1 mM) and Ro 20-1724 (0.25 mM) enhanced the inhibitory effects of PGE1, forskolin, and isoprenaline (Figure 9 ), demonstrating that the inhibition is mediated by cyclic AMP.
Discussion
The activation of T-lymphocytes is a multistep process. Two of the first signals which can be observed biochemically are an elevation of the free intracellular Ca2+ concentration and the hydrolysis of phosphatidyl-inositol-bisphosphate into inositol-(1,4,5)-trisphosphate (1P3) and diacylglycerol (DAG) leading to activation of a protein kinase C (Chen et al., 1986; Cambier et al., 1987; Linch et al., 1987; Gelfand et al., 1987; Hadden, 1988; Gupta, 1989) . Although generation of IP3 is the major stimulus to elevate intracellular Ca2+ in many model systems (Berridge & Irvine, 1989) it is still a matter of debate whether
Ca"2+ increases in lymphocytes by mitogenic lectins are caused by 1P3 or not (King, 1988) . Our study did not directly address this question, but the observation that PWM was approximately half as effective as Con A in generating inositol phosphates but a very poor stimulus for Ca2+ elevations support the idea that Ca2+ influx in lymphocytes may not necessarily be predominantly caused by inositol phosphate generation.
In our study, we have used the T-lymphocyte specific mitogenic lectins PHA and Con A and the non-specific B-and T-lymphocyte mitogen PWM to mimic the activation of resting lymphocytes by antigens. The characteristics of inositol phosphate generation and elevation of intracellular Ca2 + in human MNL as stimulated by PHA, Con A and PWM in our and other studies (i.e. concentration-dependency; dependency of Ca2+ increase on influx; lack of pertussis toxin sensitivity) are very similar to those described previously for other polyclonal T-lymphocyte activators such as monoclonal anti-CD3 antibodies (for review see Chen et al., 1986; (Bourne et al., 1974; Felten et al., 1987; Feldman et al., 1987; Mary et al., 1987; Kammer, 1988; Johnson et al., 1988) . Whether this inhibitory effect of cyclic AMP, however, is due to interaction with the phospholipase C/IP3/DAG pathway, is still a matter of debate. Imboden et al. (1986) and Sommermeyer & Resch (1990) found in the human T cell tumour line Jurkat that cholera toxin (which via ADP-ribosylation activates the adenylate cyclase coupled G,-protein thereby stimulating cyclic AMP formation) inhibits antigen-induced 'P3-formation and increases in intracellular Ca2", but this effect could not be mimicked by other cyclic AMP increasing agents and/or cyclic AMP analogues. On the other hand, Lerner et al. (1988) (PGEJ) or -independent (forskolin), evoked inhibition of IP3 formation and increases in intracellular Ca2+.
These data prompted us to investigate in mixed human lymphocytes the effects of various agents known to stimulate the formation of cyclic AMP on the mitogen-induced generation of inositol phosphates (as a parameter of phosphatidylinositol-bisphosphate hydrolysis) and increases in intracellular Ca2 +. The results clearly demonstrate that all agents used in this study that elevate cyclic AMP levels (see Table 1 ) also inhibit mitogen-induced generation of inositol phosphates and increases in the intracellular Ca2 + concentration.
The fact, that (i) inhibition of the break-down of cyclic AMP by phosphodiesterase inhibitors potentiated the inhibition of inositol phosphate generation and of intracellular Ca2 + rises and (ii) the amount of inhibition of inositol phosphate generation was strongly related to the magnitude of cyclic AMP elevations is in favour of the idea that cyclic AMP is responsible for inducing these inhibitory effects. Thus, the present data obtained in human MNL confirm those of Lerner et al. (1988) obtained in mouse T-lymphocytes and of Windebank et al. (1988) obtained in cloned human NK cells, that cyclic AMP-induced inhibition of cell proliferation and cytotoxicity, respectively, is accompanied (and/or induced?) by inhibition of increases in the intracellular Ca2+ concentrations and generation of inositol phosphates.
In the present study, fi-adrenoceptor agonists increased the intracellular cyclic AMP content and inhibited the mitogeninduced generation of inositol phosphates with an order of potency: isoprenaline > adrenaline > noradrenaline. This order of potency (Lands et al., 1967) and the fact that catecholamine-induced inhibition of inositol phosphate generation could be abolished by the fi2-adrenoceptor selective antagonist ICI 118,551 (Bilski et al., 1983) but not affected by the /J1-adrenoceptor selective antagonist CGP 20712 A (Dooley et al., 1986) Brodde et al., 1987) .
It should be noted that cyclic AMP (a) inhibited inositol phosphate generation and Ca2 + increases, although both responses may occur independently; (b) inhibited the second messenger generation by all three mitogens, although they may stimulate second messenger generation via at least partially different pathways (see above); and (c) inhibited second messenger generation whether near maximally effective (Con A and PWM) or low (PHA) mitogen concentrations were used. Thus, our data suggest a prominent role of cyclic AMPincreasing agents in the regulation of the generation of second messengers which are important in the activation of resting lymphocytes.
Taken together our data demonstrate that catecholamines can attenuate the generation of two second messengers which are important in the activation of resting human lymphocytes. This appears to be mediated via fl2-adrenoceptors by elevating 
